Use Repetitive Transcranial Magnetic Stimulation to Treat Somatic Symptom Disorder

Recruiting now · Not applicable · Has a placebo group

Conditions studied: Somatic Symptom Disorder

In brief

This is a randomized double-blind sham-controlled crossover study; the interventions are high-frequency rTMS stimulation on left DLPFC and sham control. The study population is the patient with somatic symptom disorder. The primary outcomes are somatic distress and health anxiety.

Key facts

Study ID

NCT05161819

Run by

National Taiwan University Hospital

People needed

30

Starts

2022-08-29

Expected to finish

2026-12-31

Last updated by the study team

2026-03-18

Who can join

Age: 20 and older, up to 70. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Patient with somatic symptom disorder (confirmed by psychiatrists)
• Age 20-70

You may not qualify if…

• Having psychotic symptoms or cognitive impairment
• Having potentially lethal illness
• Using cardiac pacemakers or defibrillators
• Currently pregnant or having plans to become pregnant within the next three months
• Received rTMS treatment within three months
• Cannot read the questionnaires by oneself
• Having to take the following medications persistently: bupropion >300 mg/day、TCA、clozapine、chlorpromazine、foscarnet、ganciclovir、ritonavir、theophylline

Where it is running

• National Taiwan University Hospital Yunlin Branch — Douliu, Yunlin, Taiwan (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.